Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo‐controlled Trial of Bupropion von Patterson, F, Schnoll, RA, Wileyto, EP, Pinto, A, Epstein, LH, Shields, PG, Hawk, LW, Tyndale, RF, Benowitz, N, Lerman, C

Volltext

Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended‐Duration Transdermal Nicotine Therapy von Lerman, C, Jepson, C, Wileyto, E P, Patterson, F, Schnoll, R, Mroziewicz, M, Benowitz, N, Tyndale, R F

Volltext

Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype von Loughead, J, Wileyto, E P, Valdez, J N, Sanborn, P, Tang, K, Strasser, A A, Ruparel, K, Ray, R, Gur, R C, Lerman, C

Volltext

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial von Lerman, C, Wileyto, E P, Patterson, F, Rukstalis, M, Audrain-McGovern, J, Restine, S, Shields, P G, Kaufmann, V, Redden, D, Benowitz, N, Berrettini, W H

Volltext

Distinguishing risk factors for the onset of cravings, withdrawal symptoms and tolerance in novice adolescent smokers von Wileyto, P, O’Loughlin, J, Lagerlund, M, Meshefedjian, G, Dugas, E, Gervais, A

Volltext

244MO A phase II trial targeting disseminated dormant tumor cells with hydroxychloroquine, everolimus or the combination to prevent recurrent breast cancer (“CLEVER”) von DeMichele, A., Clark, A.S., Bayne, L., Rohn, K., Nivar, I., Wileyto, P., Berry, L., DeLuca, S., Savage, J., Makhlin, I., Pan, T.C., Graves, J., Belka, G., Wang, J., Shih, N., Berry, D., Nayak, A., Feldman, M., Chodosh, L.

Volltext

CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma von Berger, I., Simpson, Scott, Friedberg, JS, Culligan, Melissa J., Wileyto, E. Paul, Alley, Evan W., Sterman, D., Patel, Akash M., Khalid, U., Simone, CB, Cengel, Keith A., Katz, Sharyn I., Roshkovan, L.

Volltext

CREB1 haplotypes and the relative reinforcing value of nicotine von Ray, R, Jepson, C, Wileyto, P, Patterson, F, Strasser, A A, Rukstalis, M, Perkins, K, Blendy, J, Lerman, C

Volltext

Loss of SMAD4 Expression Associated with Worse Progression-Free and Overall Survival in Patients with Pancreatic Adenocarcinoma Treated Surgically von Baumann, B.C., Shroff, S., Wileyto, P., Meyer, A., Tangsriwong, K., Li, J., Plastaras, J.P., Metz, J.M., Furth, E.E., Ben-Josef, E.

Volltext

APOE epsilon 4, an Alzheimer's disease susceptibility allele, and smoking cessation von Ashare, R L, Karlawish, J H, Wileyto, E P, Pinto, A, Lerman, C

Volltext

Risk Factors for Lyme Disease in Chester County, Pennsylvania von Smith, Gary, Wileyto, E. Paul, Hopkins, Robert B., Cherry, Bryan R., Maher, John P.

Volltext

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study von Schnoll, Robert A., Patterson, Freda, Wileyto, E. Paul, Tyndale, Rachel F., Benowitz, Neal, Lerman, Caryn

Volltext

O2-1.1 Multidrug resistant tuberculous meningitis in the United States, 1993–2005 von Vinnard, C, Winston, C, Wileyto, E P, MacGregor, R R, Bisson, G

Volltext

Changes in food reward following smoking cessation: a pharmacogenetic investigation von Lerman, Caryn, Berrettini, Wade, Pinto, Angela, Patterson, Freda, Crystal-Mansour, Susan, Wileyto, E Paul, Restine, Stephanie L, Leonard, Debra G B, Shields, Peter G, Epstein, Leonard H

Volltext

μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief von Falcone, Mary, Gold, Allison B., Wileyto, E. Paul, Ray, Riju, Ruparel, Kosha, Newberg, Andrew, Dubroff, Jacob, Logan, Jean, Zubieta, Jon-Kar, Blendy, Julie A., Lerman, Caryn

Volltext

Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations von EVANS, S. M, LEW, R, KOCHMAN, M. L, WILEYTO, E. P, BAUM, E, SAFFORD, K. M, KOCH, C. J

Volltext

Abstract OT2-07-09: Detection and targeting of minimal residual disease in breast cancer to reduce recurrence: The PENN-SURMOUNT and CLEVER trials von Bayne, LJ, Nivar, I, Goodspeed, B, Wileyto, P, Savage, J, Shih, NNC, Feldman, MD, Edwards, J, Clark, AS, Fox, KR, Matro, JM, Domchek, SM, Bradbury, AR, Shah, PD, Chislock, EM, Belka, GK, Wang, J, Amaravadi, R, Chodosh, LA, DeMichele, AM

Volltext

Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco d... von Dahl, J P, Jepson, C, Levenson, R, Wileyto, E P, Patterson, F, Berrettini, W H, Lerman, C

Volltext

Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study von Vinnard, Christopher, Winston, Carla A, Wileyto, E Paul, MacGregor, Rob Roy, Bisson, Gregory P

Volltext

P17.04.B A PHASE 2 STUDY OF NIRAPARIB CONCOMITANT WITH TUMOR TREATING FIELDS (TTFIELDS) IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG) von Bagley, S J, Mansour, M, Pantel, A, Schubert, E, Dulal, C, Nabavizadeh, A, Mohan, S, Maloney, E, Prior, T, Angeloni, N, Blessing, C, Frangos, S, Coghlan, L, Wileyto, E P, O'Rourke, D, Brem, S, Desai, A

Volltext